2252 — Shanghai MicroPort MedBot Co Income Statement
0.000.00%
Last trade - 00:00
- HK$12.75bn
- HK$12.82bn
- CNY104.59m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 2.15 | 21.6 | 105 |
Cost of Revenue | |||||
Gross Profit | 0 | 0 | 0.919 | 6.56 | 14.7 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 69.3 | 158 | 554 | 1,117 | 1,080 |
Operating Profit | -69.3 | -158 | -552 | -1,095 | -975 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -69.8 | -209 | -585 | -1,146 | -1,024 |
Provision for Income Taxes | |||||
Net Income After Taxes | -69.8 | -209 | -585 | -1,146 | -1,024 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -69.8 | -209 | -583 | -1,140 | -1,012 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -69.8 | -209 | -583 | -1,140 | -1,012 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.073 | -0.219 | -0.59 | -1.19 | -1.01 |